HSCS (HeartSciences) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSCS HeartSciences Inc HSCS
49 GF Score
Price $2.74
GF Value $2.59
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is HeartSciences Net Loan?

Net Loan only applies to banks and insurance companies.

HSCS
49GF Score
HeartSciences Inc HSCS
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.74 is trading 5.8% above its estimated GF Value™ of $2.59. GuruFocus considers HeartSciences to be Fairly Valued.

Key valuation signals for HSCS:

  • Net Loan:
  • GF Value™: $2.59 vs. price of $2.74 (5.8% above fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
49GF Score

Get the complete analysis for HSCS

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.74
Price
$2.59
GF Value